Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 70858 CHARLOTTE, NC
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$218,840
-$403,451 QoQ
Shares Held
46,861
-68.9% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 89 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. XFOR ranks #282 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in XFOR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $218,840 46,861
2026-03-31 $622,291 150,676
2025-12-31 $143,044 35,761
2025-09-30 $66,019 19,304
2025-06-30 $152,600 80,316
2025-03-31 $18,251 77,340
2024-12-31 $97,990 133,502
2024-09-30 $74,270 111,017
2024-06-30 $52,754 90,957
2024-03-31 $142,769 102,712
2023-12-31 $178,612 212,888
2023-09-30 $406,779 373,193
2023-06-30 $86,985 44,838
2022-12-31 $270 272
2022-09-30 $1 1
2022-06-30 $0 1
2022-03-31 $10,928 6,245
2021-12-31 $21,539 9,406
2021-09-30 $90,892 17,182
2021-06-30 $146,365 22,518
2021-03-31 $272,961 31,703
2020-12-31 $126,348 19,650
2020-09-30 $106,349 15,709
2020-06-30 $160,061 17,174
2020-03-31 $61,608 6,161